JPRN-UMIN000022941已完成未知
Effect of intake of supplements containing ornithine on human health. - Ornithine clinical trial
aboratory of Systematic Forest and Forest Products Science, Faculty of Agriculture, Kyushu University0 个研究点目标入组 40 人开始时间: 2017年9月24日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 65years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1)Persons who have any dietary supplements, quasi drugs or medicines which cause same or similar efficay with the effect evaluated in this study (2)Persons who changed their habitats of supplements whitin 4 weeks. (3)Persons who work in night shift or in day and night shift (4)Persons who have been treated their illness or prevention in a clinic at their informed consent (5)Persons with their medical histories as follows: serious diseases of Sugar metabolism,lipid metabolism, liver function, renal function, heart, circulatory, respiratory, endocrine system, immune system, or mental illness of the nervous system (6)persons with the medical histories of alcoholism or drug dependence (7)persons who might be developed allergic reaction to foods. (8)Persons who are pregnant, breast-feeding, or hope to be pregnant during the study preiod (9)persons who had always participated in or will participate in any other clinical trial (to use foods/medicine/quasi medicine/medical device) (10)persons who will not be judged suitable to the participants by the investigator.
研究者
相似试验
招募中
不适用
The effect of oral nutritional supplement (ONS) on the prognostic nutritional index (PNI) during neoadjuvant chemotherapy for gastric cancergastric cancerJPRN-UMIN000012598ara Medical University40
已完成
不适用
Effect of an oral nutritional supplement therapy on muscle mass, bone metabolism, body composition, growth, and disease activity in pediatric Crohn’s Disease: a controlled trialDRKS00010278Klinikum der Universität München, Campus Großhadern42
招募中
不适用
The effects of oral nutritional supplement (ONS) during chemoradiotherapy in patients with pancreatic and/or esophageal cancerPatients with pancreatic and/or esophageal cancer, who are scheduled to receive chemoradiotherapyJPRN-UMIN000006274Osaka Medical Center for Cancer and Cardiovascular Diseases Department of Medical Oncology50
招募中
3 期
Efficacy of oral nutritional supplements for the prevention of body weight loss after surgery to gatric cancerGastric cancerJPRN-jRCTs051230012Obama Kazutaka120
进行中（未招募）
1 期
Study to test the effect of the drug L-ornithine.L-aspertate (LOLA) on microorganisms in the digestive tract in patients with liver cirrhosis (damage of the liver due to liver disease)iver cirrhosis with covert or overt hepatic encephalopathy (grade 0-2)MedDRA version: 20.0Level: LLTClassification code 10024667Term: Liver cirrhosisSystem Organ Class: 100000004871MedDRA version: 20.0Level: LLTClassification code 10014630Term: Encephalopathy hepaticSystem Organ Class: 100000004852EUCTR2022-002924-11-ATCBmed GmbH55